Association of a polymorphism of BTN2A1 with dyslipidemia in East Asian populations

Experimental and Therapeutic Medicine

Volumn 2, Issue 4, 2011, Pages 745-749

  Fujimaki, Tetsuo ^a   Kato, Kimihiko ^b   Oguri, Mitsutoshi ^c   Yohida, Tetsuro ^a   Horibe, Hideki ^d   Yokoi, Kiyoshi ^d   Watanabe, Sachiro ^e   Satoh, Kei ^f   Aoyagi, Yukitoshi ^g   Tanaka, Masashi ^g   Yoshida, Hiroto ^g   Shinkai, Shoji ^g   Nozawa, Yoshinori ^h   Shin, Dong Jik ⁱ   Lee, Jong Ho ^i,j   Jang, Yangsoo ^k   Yamada, Yoshiji ^b  

^a Inabe General Hospital   (Japan)

^b MIE UNIVERSITY   (Japan)

^c JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^d GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^e GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^f HIROSAKI UNIVERSITY   (Japan)

^g TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^h GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

ⁱ Yonsei University   (South Korea)

^j Department of Food and Nutrition   (South Korea)

^k Yonsei University College of Medicine   (South Korea)

more..

Author keywords

Dyslipidemia; Genetics; Hyperlipidemia hypercholesterolemia; Polymorphism

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; DNA POLYMORPHISM; DYSLIPIDEMIA; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HUMAN; JAPANESE; KOREA; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

EID: 79958051579     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.266     Document Type: Article

References (21)

1. Khera AV and Rader DJ: Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics. Trends Cardiovasc Med 19: 195-201, 2009.
2. Ordovas JM: Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc 106: 1074-1081, 2006.
3. Aulchenko YS, Ripatti S, Lindqvist I, et al: Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47-55, 2009.
4. Kathiresan S, Melander O, Guiducci C, et al: Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 40: 189-197, 2008.
5. Kathiresan S, Willer CJ, Peloso GM, et al: Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41: 56-65, 2009.
6. Yamada Y, Nishida T, Ichihara S, et al: Association of a polymorphism of BTN2A1 with myocardial infarction in East Asian populations. Atherosclerosis 215: 145-152, 2011.
7. Yamada Y, Matsuo H, Warita S, et al: Prediction of genetic risk for dyslipidemia. Genomics 90: 551-558, 2007.
8. Itoh Y, Mizuki N, Shimada T, et al: High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57: 717-729, 2005.
9. Garg A and Simha V: Update on dyslipidemia. J Clin Endocrinol Metab 92: 1581-1589, 2007.
10. Rhodes DA, Stammers M, Malcherek G, Beck S and Trowsdale J: The cluster of BTN genes in the extended major histocompatibility complex. Genomics 71: 351-362, 2001.
11. Heid HW, Winter S, Bruder G, Keenan TW and Jarasch ED: Butyrophilin, an apical plasma membrane-associated glyco-protein characteristic of lactating mammary glands of diverse species. Biochim Biophys Acta 728: 228-238, 1983.
12. Arnett HA, Escobar SS and Viney JL: Regulation of cost imulation in the era of butyrophilins. Cytokine 46: 370-375, 2009.
13. Hsueh KC, Lin YJ, Chang JS, Wan L and Tsai FJ: BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children. Eur J Pediatr 169: 713-719, 2010.
14. Valentonyte R, Hampe J, Huse K, et al: Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37: 357-364, 2005.
15. Rybicki BA, Walewski JL, Maliarik MJ, Kian H and Iannuzzi MC: The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 77: 491-499, 2005.
16. Khovidhunkit W, Kim MS, Memon RA, et al: Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45: 1169-1196, 2004.
17. Gallin JI, Kaye D and O'Leary WM: Serum lipids in infection. N Engl J Med 281: 1081-1086, 1969.
18. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E and Taskinen MR: Changes in serum lipoprotein pattern induced by acute infections. Metabolism 37: 859-865, 1988.
19. Chen X, Xun K, Chen L and Wang Y: TNF-alpha, a potent lipid metabolism regulator. Cell Biochem Funct 27: 407-416, 2009.
20. McGillicuddy FC, de la Llera Moya M, Hinkle CC, et al: Infammation impairs reverse cholesterol transport in vivo. Circulation 119: 1135-1145, 2009.
21. Reiss AB: Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus. Curr Rheumatol Rep 11: 255-260, 2009.